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ABSTRACT: Multiple diseases are at some point associated with
altered endothelial function, and endothelial dysfunction (ED)
contributes to their pathophysiology. Biochemical changes of the
dysfunctional endothelium are linked to various cellular organelles,
including the mitochondria, endoplasmic reticulum, and nucleus,
so organelle-specific insight is needed for better understanding of
endothelial pathobiology. Raman imaging, which combines
chemical specificity with microscopic resolution, has proved to
be useful in detecting biochemical changes in ED at the cellular
level. However, the detection of spectroscopic markers associated
with specific cell organelles, while desirable, cannot easily be
achieved by Raman imaging without labeling. This critical review
summarizes the current advances in Raman-based analysis of ED,
with a focus on a new approach involving molecular Raman reporters that could facilitate the study of biochemical changes in cellular
organelles. Finally, imaging techniques based on both conventional spontaneous Raman scattering and the emerging technique of
stimulated Raman scattering are discussed.
1. INTRODUCTION
Endothelial cells line the lumen of all the vessels in the body,
from the heart to the capillaries,1 and can be regarded as the
unique organ of the body that maintains cardiovascular
homeostasis and accomplishes multiple roles by its endocrine,
paracrine, and autocrine functions. The best studied is the
endothelium-dependent regulation of vascular tone, performed
through a fine-tuned balance between the activity of
endothelial mediators with vasodilatory effects (e.g., nitric
oxide (NO), prostacyclin (PGI2), and epoxyeicosatrienoic
acids (EETs)) or vasoconstricting effects (e.g., endothelin-1
(ET-1), thromboxane A2 (TXA2), and angiotensin II (Ang
II)).1−3 The endothelium regulates not only blood flow but
also vascular permeability, adhesion of platelets and leukocytes
to the endothelium, proliferation of smooth muscle cells,
immune and inflammatory response, thrombotic processes,
and angiogenesis. The mechanisms involved in the endothe-
lium-dependent regulation of these processes are complex and
involve hundreds of mediators, as reviewed elsewhere.4−7
Their concerted harmonized action featuring a healthy
endothelium is essential for undisturbed functioning of the
cardiovascular system, while endothelial dysfunction (ED) is
recognized as a hallmark of various cardiovascular diseases. ED
is closely interconnected with oxidative stress, decreased ·NO
bioavailability, and vascular inflammation, representing unify-
ing concepts for the underlying pathophysiology of cardiovas-
cular morbidity and mortality.8 In fact, impaired ·NO signaling,
vascular inflammation, and oxidative stress are key players in
the pathogenesis of ED in various diseases.
Various classical risk factors (e.g., hypercholesterolemia,
hypertension, chronic smoking, or diabetes mellitus) or
nonclassical risk factors such as the influence of the
environment (e.g., traffic noise exposure, ambient air pollution,
and mental stress) or chronic inflammatory disease (e.g.,
rheumatoid arthritis or psoriasis) can induce ED. Moreover, a
few risk factors produce a synergistic effect on endothelial
function as well as the associated cardiovascular prognosis.8
There is no doubt today that endothelial phenotype represents
a real barometer of cardiovascular risk.9 However, despite over
5 decades of research, there is still a huge bench-to-bedside gap
in endothelial biomedicine.10 One of the limitations on our
understanding of endothelial physiology and pathophysiology
is the huge complexity and heterogeneity of the endothelium
and the paucity of experimental imaging methods that can be
used for in-depth characterization of biochemical alterations of
the endothelial phenotype.
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Given the unique features of Raman spectroscopy to identify
the chemical signatures of substances, here we critically review
the ability of Raman microscopy to define the biochemical
phenotype of ED. First, a summary of recent studies
characterizing ED with the use of Raman spectroscopy is
provided. Next, a critical review of the possibility of detecting
subcellular alterations of the nucleus, mitochondria, endoplas-
mic reticulum, and lysosomes by a novel approach that
combines Raman imaging with molecular reporters is
described. Finally, we comment on imaging techniques based
on both conventional spontaneous Raman scattering and the
emerging technique called stimulated Raman scattering.
2. RAMAN SPECTROSCOPIC MARKERS OF
ENDOTHELIAL DYSFUNCTION STUDIED EX VIVO
IN ISOLATED VESSELS
Raman spectroscopy is based on the inelastic scattering of
photons known as the Raman effect. It was first discovered by
C. V. Raman in 1928.11 Raman scattering is induced by
monochromatic light directed into the sample where photons
interact with the molecules, which then emit photons of the
same (Rayleigh), lower (Stokes), and higher energy (anti-
Stokes) than the absorbed photons. The Raman spectrum is
generated upon detection of the scattered photons in an
inelastic way by a molecule. Each molecule has a unique
spectrum in which certain bands correspond to specific
functional groups and the intensity of the bands can be
correlated with the concentration of the analyzed compound in
a given sample. Therefore, Raman spectroscopy can be used
both for qualitative and quantitative analyses.12,13
A set of relatively new techniques based on Raman
spectroscopy has been developed to enhance the acquired
Raman signal or to increase the sensitivity and/or selectivity of
detection, especially in biological samples. An example of such
techniques is resonance Raman (rR) spectroscopy, in which
the laser excitation line is aligned to match the electronic
transition of a targeted molecule. As a consequence, an
enhancement of the intensity of the scattered Raman radiation
by a factor of up to 106 can be observed, improving the
detection of a selected compound.14 Another technique that
allows Raman signal enhancement of up to 108 times and high
imaging speed is stimulated Raman scattering (SRS)
microscopy.15,16 SRS is a background-free nonlinear technique
that requires the use of two ultrafast pulsed laser lines, denoted
as the pump and probe. This technique has gained popularity
because of its potential to improve sensitivity and reduce
Figure 1. Raman imaging of endothelial dysfunction (ED) studied ex vivo. (top) Imaging of lipid rafts in en face aorta in db/db mice: (A)
microphotograph of a studied tissue; (B) Raman image obtained by integration in the region 2830−3030 cm−1; (C) topography and (D) phase
AFM images; (E−H) confocal micrographs of (E, F) db/db and (G, H) db+ tissue fragments showing endothelial caveolin-1 (red), cell nuclei
(blue), and elastin (green). From ref 21. CC BY 4.0. (bottom) Raman investigation of a NO-deficient hypertensive murine model: (A) confocal
micrographs of thoracic aorta cross-section of a control mouse; (B) cluster image and (C) average spectra of classes corresponding to the
endothelium (red), cell nuclei (blue), and elastin fibers (green), along with (D) average spectra taken from the endothelium region of control
(blue), hypertensive (red), and nitrate-treated (green) mice; (E, F) deconvolution of the amide I band for (E) control and (F) hypertensive mice,
where the blue and red lines correspond to the α-helix (1656 cm−1) and the β-sheet (1668 cm−1), respectively, and the green line is the sum of all
bands.25 Adapted with permission from ref 25. Copyright 2014 Royal Society of Chemistry.
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measurement time. Furthermore, electronic preresonance
stimulated Raman scattering (epr-SRS) microscopy has been
developed as a novel technique that benefits from the
synergetic effect of rR and SRS.17 This technique holds great
potential to utilize Raman reporters to increase remarkably the
sensitivity of the Raman measurements.
Raman spectra of cells are complex since they contain
information about all of the molecules present in the sample,
but they are especially useful in studying lipids, proteins, and
nucleic acids, providing insight into chemical structure and
changes in the cells. Confocal Raman microscopy has many
advantages over other widely used imaging methods such as
fluorescence imaging; it has high chemical specificity and
generally does not require labels that could influence the
outcome of the study. Moreover, Raman spectroscopy allows
imaging of cells in aqueous environments since water has a
weak Raman signal.11 This makes Raman microscopy a reliable
tool to study biochemical processes in cells and tissues, e.g., to
follow the development of a disease. Indeed, Raman spectros-
copy has been successfully used in our previous studies to
investigate the changes associated with ED using in vitro and ex
vivo models of atherosclerosis, diabetes, and hypertension,
often combined with complementary techniques.18
For example, 3D confocal Raman imaging combined with
atomic force microscopy (AFM) provides a valuable insight
into biochemical content in relation to nanomechanics of ED.
Through processing of the acquired Raman spectra, this
technique offers valuable information on the chemical
structures of the samples and the distribution of certain
biological molecules (i.e., lipids, proteins, etc.) while AFM
offers insight into the samples’ nanomechanical properties,
allowing the acquisition of comprehensive information on ED
phenotype. Although the mechanisms of diabetes-induced ED
have been addressed in multiple studies,19 3D confocal Raman
imaging combined with AFM of split-open (en face) aorta of a
genetically modified murine model of type 2 diabetes mellitus
(db/db) provided a novel insight into the chemical content
and nanomechanical aspects of the endothelium.20 A
significant increase in the area occupied by lipid rafts was
observed, along with an overall increase in lipid content in the
aorta of diabetic mice associated with an increase in the lipid to
protein ratio (Figure 1, top).21 Interestingly, through Raman
spectroscopy-based detection of protein and lipid bands in a
cross section and en face aorta it was possible to distinguish
between pathology and control.22 In fact, hierarchical cluster
analysis (HCA) classified endothelial dysfunction in diabetes
with 88% sensitivity and >94% specificity.
ED in hypertension is also linked to NO deficiency,23,24
similarly as in diabetes. However, label-free Raman imaging
detected distinct alterations in the hypertensive state versus
control as compared with diabetes.25 A significant change in
the Raman spectra in the 1200−1400 cm−1 region due to
alteration of the secondary structure of proteins in NO-
deficient hypertensive mice was observed, where an increase in
the intensity of the band at 1254 cm−1 and a significant
decrease in the intensity of the band at 1281 cm−1 signaled an
increase in the relative amount of the β-sheet structure relative
to the α-helix structure (Figure 1, bottom). Furthermore, a
decrease in the lipid to protein ratio upon pathology
development was detected. While a nitrate supplement
restored the balance in the lipid to protein ratio, the structural
changes of endothelial proteins were not modified.25 HCA
results enabled the discrimination between NO-deficient and
control animal samples on the basis of the position and shape
of the amide III band (1222−1374 cm−1) and the lipid to
protein ratio, with both sensitivity and specificity of ca. 93%.22
In turn, in a murine model of atherosclerosis in
apolipoprotein E and low-density lipoprotein receptor
(LDLR) double-knockout (ApoE/LDLR−/−) mice,26
Raman-based features of ED were dominated by lipid signals.
A significant increase in the intensity of the C−H stretching
band (2800−3030 cm−1) by +17% was observed in the ApoE/
LDLR−/−, mice indicating an increase in the intracellular lipid
content. Moreover, compared with wild-type mice, endothelial
cells from ApoE/LDLR−/− mice showed a significant increase
in cortical stiffness, suggesting that impairment of NO-
dependent function was linked to increased lipid endothelial
accumulation and cortical stiffness.27
Raman spectroscopy also revealed that the tyrosine (Tyr) to
phenylalanine (Phe) ratio was changed in ED in athero-
sclerosis.28 Tetrahydrobiopterin (BH4) is a key regulator of
endothelial nitric oxide synthase (eNOS), and therefore,
limitation of BH4 availability triggers ED and is reflected by
changes in the synthesis of Tyr from Phe that depend on the
presence of BH4 as a cofactor of phenylalanine hydroxylase
(PAH).29 Accordingly, alterations in the Tyr to Phe ratio may
indicate ED. The relative intensities of characteristic Raman
bands of Phe (1004 cm−1) and Tyr (854 cm−1) were analyzed
in samples taken from the aorta of atherosclerotic (ApoE/
LDLR−/−) mice compared with 1-methylnicotinamide
(MNA)-treated and control mice.30 The results showed that
the Tyr to Phe ratio was significantly lower for ApoE/LDLR−/
− samples compared with the control.30 Moreover, this ratio
slightly increased in mice treated with MNA,30 an agent known
to improve endothelial function in ApoE/LDLR−/− mice.31,32
Overall, Raman spectroscopy has the potential to detect
spectroscopic markers of ED and to uncover biochemical
changes associated with ED that to some degree seems to be
disease-specific. Indeed, in our previous studies in animal
models of ED in diabetes, hypertension, and atherosclerosis,
markers of ED were specific for each of the studied
diseases.21,22,25,27 Still, the subcellular origin of these changes
could not be detected, and therefore, it was not possible to
establish which organelle was involved in the development of
ED in these models.
3. LABEL-FREE AND LABELED RAMAN IMAGING OF
CELLULAR ORGANELLES
One of the advantages of Raman microscopy is the ability to
obtain information about the chemical composition of
biological samples without the need to introduce dyes (labels).
Label-free Raman imaging offers reliable information on the
distribution and chemical composition of various biological
components (i.e., nucleic acids, proteins, lipids, etc.). However,
their characteristic Raman bands can overlap. Therefore, even
though this technique is capable of detecting several changes
associated with the development of endothelial pathology, the
sensitivity and selectivity of subcellular imaging is limited and
could be significantly improved using molecular Raman
reporters, a method called labeled Raman imaging. Such
reporters would ideally have a targeting moiety specific to
certain organelles and a Raman reporting moiety that would
enhance the obtained Raman signal or give a strong band in
the biologically silent spectral region (1800−2800 cm−1).
Alternatively, isotopic labeling of certain molecules (e.g.,
substitution of protons with deuterium) has the potential to
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detect cellular responses under various conditions since
molecular vibrations of isotope-labeled groups are different
than all of the others. It is worth mentioning that using
molecular Raman reporters requires an extra step of sample
treatment, during which the reporters’ properties such as their
light sensitivity, solubility, cellular uptake, and possible cellular
effects should be taken into consideration, although ideally
Raman reporters are desired to be inert or have a negligible
effect on the samples.
Table 1. Summary of Raman Reporters
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The possibilities and limitations of imaging the interior of
cells with label-free or labeled approaches are discussed below.
The cell organelles (i.e., mitochondria, endoplasmic reticulum,
nucleus, and lysosomes) were selected on the basis of the
available literature indicating the applicability of both
approaches as well as their importance in the context of
mechanisms of ED.33−35 Table 1 presents selected compounds
and indicates their molecular structures responsible for the
Raman signal and their affinities to specific subcellular
organelles separately. The structures of commercially available
dyes utilized in EPR-SRS are not shown.
3.1. Mitochondria. Endothelial cells undergo mainly
anaerobic glycolytic metabolism, but the role of mitochondrial
oxidative phosphorylation to produce ATP and regulate the
endothelial phenotype is increasingly appreciated.36−38 In the
context of ED, mitochondrial reactive oxygen species (ROS)
are fundamental in the regulation of vascular signaling, such as
endothelial proliferation, shear-stress-induced vasodilation, and
apoptosis. On the other hand, an excess of ROS has multiple
harmful effects on mitochondrial DNA, on the bioavailability
of NO, which reacts with superoxide to form peroxynitrite, and
on lipid peroxidation. Increased mitochondrial ROS are also
implicated in cell death pathways like programmed necrosis
(necroptosis) and apoptosis. There are a number of
pathophysiological situations whereby alterations of mitochon-
drial function contribute to ED, such as hyperglycemia and
diabetes,36,39−41 Ang-II-induced ED,42−44 and atherosclero-
sis.36
The presence of cytochrome complex inside mitochondria
allows for selective label-free Raman imaging of its distribution
based on a set of characteristic bands (at approximately 750,
1130, 1310, and 1590 cm−1), especially when the measure-
ments are performed under rR conditions resulting in
enhancement of the cytochrome c bands.45,46 Apoptosis
occurring in the mitochondrial pathway is characterized by
the release of cytochrome c to the cytoplasm, which shows the
utility of Raman spectroscopy studies of cytochrome
distribution.45 However, under off-resonance conditions
(using excitation light of wavelength above 550 nm)
characteristic cytochrome c bands may be masked by Raman
signals from dominant intracellular components (e.g., proteins
and lipids).47 Therefore, we emphasize that label-free Raman
imaging of cytochrome is limited to measurements carried out
under resonance conditions (laser line in the range of the
cytochrome c absorption band) and for living cells. Since
mitochondria occupy only 2−6% of the endothelial cytoplasm
volume, nonresonance imaging may result in an inability to
detect the cytochrome c bands.37,47
Therefore, the application of so-called Raman reporters (also
known as Raman probes or Raman tags) that give a strong
Raman scattering peak in the spectrally silent region (1800−
2800 cm−1) enables more specific Raman imaging of
subcellular structures. Spontaneous Raman and SRS studies
showed the potential of bis(aryl)butadiyne (BADY) and its
derivatives combined with triphenylphosphonium cation
(TPP+) as a mitochondrial targeting moiety (Figure 2A).48,49
The charge brought by TPP+ in MitoBADY is easily targeted
to mitochondria because of highly negative mitochondrial
transmembrane potential, as proved by its colocalization with a
signal characteristic for cytochrome c and MitoTracker Green
fluorescence dye.48,50 SRS studies of the diyne molecule TTP-
BDDBPDM in living HeLa cells reported that maximum
accumulation within cell decreased by 37% after addition of
the mitochondrial membrane potential dissipating agent
CCCP.49 Moreover, TPP+ structures can be found in
combination with radical scavengers, imaging agents, or a
superoxide probe as examples of compounds with various
functions.50,51 Prasad’s group applied a similar approach that
coupled the above-described TPP+ with the azobenzene-based
probe Am-CN-Azo-OH, which allowed enhancement of the
1375 cm−1 band of MitoAzo due to electronic resonance of
Am-CN-Azo-OH under excitation with 532 nm light (Figure
2A).52 To study mitochondria distribution, analogues of
coenzyme Q, an important compound in the electron transport
chain in mitochondria, have been used. AlTQs were designed
to have similar calculated logP (clogP, where logP stands for
Figure 2. Raman subcellular imaging using molecular reporters. (A) Raman imaging of mitochondria probes MitoBADY, AlTQ2 and Mito-Azo
(left) and cytochrome c (right) in live Hela cells. Adapted with permission from refs 48, 34, and 52. Copyright 2014 Elsevier, 2012 American
Chemical Society, and 2015 Elsevier, respectively. (B) Structures of the isotopically edited RNA probe EU-13C2 (red), DNA probe EdU-
13C
(green), and fatty acid probe 17-ODYA (blue) and SRS imaging of RNA, DNA, and fatty acyl derivatives in live HeLa cells by spectral targeting of
these isotopically edited alkyne reporters. Adapted from ref 76. Copyright 2014 American Chemical Society. (C) SRS images of HeLa cells
obtained using lysosome-, mitochondria-, and nuclei-targeting PDDA (denoted as P2, P3, and P4, respectively) at 2120 cm−1, which corresponds to
the alkyne band maximum, and overlay with the lipid distribution (2850 cm−1). Scale bars: 10 μm. From ref 55, CC BY 4.0.
Journal of Medicinal Chemistry pubs.acs.org/jmc Perspective
https://doi.org/10.1021/acs.jmedchem.1c00051
J. Med. Chem. 2021, 64, 4396−4409
4400
the partition coefficient of a molecule between an aqueous
phase and a lipophilic phase) and contain active groups that
give Raman bands in the silent spectral region (Figure 2A).34
Multiplex imaging, defined as simultaneous detection of
multiple species with high sensitivity, requires narrow, well-
resolved bands. Polyyne-based reporters (denoted as Carbow)
overcame the problem of possible overlapping with bands
originating from other cellular components that have been
observed in the case of EPR-SRS imaging with commercially
available dyes. By modification of isotopes and the number of
triple bonds, Carbows cover a spectral range of 2226−2066
cm−1. Functionalization of 4-yne (Carbow2141) with TPP+
succeeded in visualization of mitochondria distribution.53
Multiple triple bonds in the polyyne structure influence the
signal intensity and enhance the chemical contrast. Water-
soluble poly(deca-4,6-diyneoic acid) (PDDA) functionalized
with organelle-targeting groups showed the potential to image
subcellular compartments with lower laser power. In order to
target the mitochondria, the PDDA was conjugated with
CGKRK, a tumor-specific homing peptide that has been shown
to bind to mitochondria of tumor cells and tumor vessel
endothelial cells.54 Colocalization of the 2120 cm−1 Raman
signal with a fluorescence image confirmed mitochondrial
targeting (Figure 2 C).55
Detection under electronic preresonance conditions is
conducted with careful laser frequency tuning into the region
of electronic preresonance, which was shown for several near-
infrared-absorbing commercially available fluorescent probes.
Mitochondria distribution was imaged with MitroTracker
Deep Red, ATTO740 immuno-labeled protein Tom20, and
rhodamine 800. The intensities of the respective bands at
1604, 1642, and 1652 cm−1 were elevated, allowing imaging of
the intracellular distribution of these dyes.56
The multiplicity of reported approaches to develop suitable
mitochondrial targeting and reporting moieties fulfilling the
criteria of nontoxicity, bioavailability, and sensitivity underline
the importance of mitochondrial-targeted mechanisms and
active research on this topic. Interestingly, the mechanism
underlying preferential accumulation of the majority of the
above-presented probes utilizes the affinity of the negatively
charged mitochondrial membrane to cationic targeting
moieties. However, their influence on mitochondrial functions
must be considered membrane potential and mitochondrial
function must be considered. Another approach worth
considering is the application of reporters such as AlTQs
that mimic the structure of important mitochondrial
mechanisms or utilize functionalized peptides.34,55
3.2. Endoplasmic Reticulum. The endoplasmic reticulum
(ER) is the largest organelle in the cell. In particular, the rough
ER is involved in the synthesis, folding, and post-translational
modification of proteins.3 Altered function of the ER, so-called
ER stress, has been repeatedly linked to the development of
ED.2,3 An example of ER stress activation is faced when the
unfolded protein response (UPR) fails to maintain the balance
between the load of new proteins to be folded and the folding
capacity of the ER or when the UPR is chronically activated.
The UPR activates pathways to reduce the newly synthesized
protein load, enhance the ER folding capacity, and activate the
ER-associated degradation machinery to dispose of irremedi-
ably misfolded proteins.2,3 All of the pathways induce the
transcription of proinflammatory signals activating the
proinflammatory regulator nuclear factor κB (NF-κB). Each
pathway acts against the ER stress but at the same time
interacts with ROS, cell death pathways, and inflammatory
signaling that are involved in the development of ED. An
example of the relation between ER stress and ED can be
found in the state of hyperglycemia, where glucose-induced
expression of inflammatory cytokines is accompanied by UPR
activation and is mitigated by chemical chaperones (e.g.,
phenylbutyric acid (PBA)).2,57 To summarize, the involvement
of the ER in ED comprises two main steps. First, ER stress is
induced through persistent activation of the UPR by numerous
substances. Free fatty acids (e.g., long-chain saturated fatty
acids), LDL oxidation (oxLDL) and oxysterols, flow
disturbance and homocysteine, and angiotensin II lead to
activation of the UPR with different mechanisms.58 Second,
the ER stress state leads to ED, impairing the balance in the
vasoactive mediators (e.g., leading to hypertension), triggering
inflammatory responses (e.g., activation of transcription factor
NF-κB), and increasing ROS production that promotes
oxidative stress (e.g., as involved in the atherogenic sequence)
and acts as a positive closed loop.2,3 Long-lasting problems
with balance maintenance of this process cause so-called ER
stress and may lead to cell death.59
Many pro-apoptotic and anticancer drugs induce endothelial
ER stress. One of them is tunicamycin (TU), which was
reported to induce endothelial toxicity and vascular dysfunc-
tions.60 TU treatment of human aortic endothelial cells
(HAoEC) showed an increase in the Raman bands character-
istic of proteins at 985 cm−1 (tryptophan), 1235 cm−1 (amide
III), and 1342 cm−1, while a decrease in characteristic
phospholipid bands was observed at 715 cm−1 (choline
N+(CH3)3) and 1072 cm
−1 (PO4
3−). Additionally, this result
was confirmed by a decrease in the intensity of lipid bands at
2855 and 2894 cm−1. Surprisingly, Raman imaging allowed the
observation of increased volume of the ER under treatment
with TU, which may indicate abnormal protein and TU
storage. A slight but not statistically significant increase in
phospholipid content was observed during the early state of
apoptosis under incubation with the apoptotic factors Fas
ligand (FasL) and cycloheximide (CHX) in a semiquantitative
analysis of the whole cell. More detailed analysis of each
cellular compartment confirmed a decrease in phenylalanine
content (1007 cm−1). In contrast to CHX, FasL-treated cells in
the ER area exhibit a red shift of the amide III band to 1254
cm−1, indicating changes in protein secondary structure, which
might correspond to caspase activity. However, the amide III
signal maximum at 1266 cm−1 after CHX treatment suggests a
different mechanism of apoptosis induction by CHX.61
SRS has been used to visualize the synthesis of proteins de
novo in the ER and their incorporation62 as well as already
existing protein degradation by incubation of cells in optimized
medium containing single or multiple stable isotope-labeled
amino acids (SILACs).63,64 Protein degradation can be
observed either in the fingerprint by introducing 13C-
phenylalanine with the ring-breathing band at 968 cm−164 or
in the cell-silent region using a mixture of deuterated leucine,
isoleucine, and valine or arginine, lysine, and methionine.63
This approach was also successfully applied to visualize protein
biosynthesis in HeLa cells transinfected with plasmid coding a
Huntington probe with a fluorescent label. A glutamin-d5-
containing medium was recently used by Miao and Wei to
image mutant Huntington protein aggregates with a long
polyglutamine chain at 2067 cm−1.65 Besides SILACs, the
alkyne-tagged analogue L-homopropargylglycine (Hpg) can be
used to image newly synthesized proteomes at 2120 cm−1.66,67
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Biosynthesis of proteins and other cellular components like
lipids can be studied with D2O, as confirmed with Raman
spectroscopy for bacteria68,69 and with SRS in in vitro and in
vivo murine models.70 Moreover, SRS has been used to
characterize the ER membrane and prove that metabolites of
external saturated fatty acid induce the formation of domains
with solid characteristics, which is impossible with a bulky
fluorescent probe such as BODIPY.71
It is noteworthy that the literature describing imaging of
only the ER with Raman reporters is rather scarce. ER imaging
with SRS was reported using pentafluorobenzamine as the
targeting moiety coupled with 4-yne.53 To date, one Raman
probe has been described that uses glibenclamide, a popular
medicine for diabetes mellitus 2 that binds to the sulfonylurea
receptors of ATP-sensitive K+ channels, mainly on the ER.51
The shortage of targeting moieties for direct ER imaging
emphasizes the challenge that both Raman and fluorescence
spectroscopy are facing in the field of ER studies and
underscores the necessity of developing alternative probes
that allow direct imaging of the ER.
3.3. Nucleus. Endothelial inflammation is associated with
the increased expression of various pro-inflammatory cytokines
and pro-thrombotic molecules and activation of various
transcription factors such as NF-κB involving activation of
nuclear transcription and chromatin rearrangement.8 On one
side, it promotes the pro-inflammatory phenotype, and on the
other side, it leads to apoptosis. Pathways leading to repair of
DNA damage are then activated (DNA damage response
(DDR)) that recruit specific DNA repair factors and effectors
(e.g., poly[ADP-ribose] polymerases (PARPs)) to repair DNA
or to induce senescence and apoptosis. However, compression
of chromatin suppresses expression of some DDR proteins and
is possibly linked with vascular calcification.72
Raman spectroscopy has been used to investigate the
changes in the nuclei and nucleoli by identifying the bands
corresponding to nucleic acids that arise from nucleotide and
sugar−phosphate backbone vibrations, specifically the bands at
ca. 788 cm−1 (phosphodiester bonds in DNA), 813 cm−1
(phosphodiester bonds in RNA), and 1095 cm−1 (phospho-
dioxy group, PO2
−).73 In another study, endothelial cells were
stimulated with FasL and CHX.61 It has been shown that
during early apoptosis a significant decrease in the protein
content is observed. However, in the FasL-stimulated cells, a
significant increase in the amounts of nucleic acids was noticed
(a marker band at 785 cm−1) that was due to the increase in
chromatin condensation.61
One of the commercially available Raman reporters that is
targeted to the nucleus is the alkyne-tagged thymidine
analogue 5-ethynyl-2′-deoxyuridine (EdU). EdU is widely
used for copper(I)-catalyzed azide−alkyne [3 + 2] cyclo-
additions with a fluorescent probe to study cell proliferation. It
easily penetrates cells or tissue samples and is incorporated
into double-stranded DNA.67,74 Alternatively, EdU has an
intense alkyne peak at 2122 cm−1.34,66,67,75,76 The concen-
tration required to successfully image incorporation of EdU is
at the same level as recommended by commercial EdU-based
fluorescence labeling kits (i.e., 20 μM) for HeLa cells incubated
with EdU for 3 or 21 h.75 It is worth underlining that EdU is
incorporated into newly synthesized DNA, as evidenced by the
lack of the 2122 cm−1 band for cells incubated with EdU in the
presence of hydroxyurea, an inhibitor of DNA synthesis.66,67
Modification with 13C isotopic substitution of the alkyne
(13C13C EdU or 13C EU) in the RNA precursor and the
alkyne-labeled lipid 17-octadecynoic acid allowed for simulta-
neous detection of tags at 2015, 2077, and 2125 cm−1 (Figure
2B).76 However, the conventional application of EdU as a click
reaction substrate to react with a commercially available near-
infrared absorbing dye such as Cy5.5 or ATTO 740 was an
interesting approach using EPR-SRS. The DNA distribution
was demonstrated using bands at 1642 and 1626 cm−1,
respectively.56 Additionally, an important nuclear protein,
histone H2B, was imaged using EPR-SRS with appropriate
labeling using far-red silicon-rhodamine displaying a strong
band at 1610 cm−1.56 Except for EdU, which shows the
distribution of newly synthesized DNA, conventional SRS
nucleus imaging is also possible with PDDA conjugated with
the cationic transactivator of transcription (TAT) peptide
CRRRQRRKKR (Figure 2C).55 Modified molecules often do
not undergo biochemical processes in cells, which may lead to
toxicity or prevent the study of more sophisticated biological
functions. However, the unnatural amino acid (UAA) Nε-[(2-
propynyloxy)carbonyl]-L-lysine was incorporated into histone
3.3−EGFP protein, expression of which in the nucleus was
visualized at 2135 cm−1, showing the potential of genetically
targeted proteins in organelle imaging.77 Although label-free
Raman microscopy enables the visualization of cell nuclei, it
does not distinguish between the nucleic acids since the
detection is mainly based on the peak at ca. 785 cm−1 that
corresponds to the ring-breathing modes of both DNA and
RNA. This point could be overcome using two different probes
for DNA and RNA detection (EdU and EU, respectively).
Nonetheless, the development of new Raman reporters that
allow faster and better imaging of DNA and RNA
simultaneously would be of great interest.
3.4. Lysosomes. Lysosomes are involved in the complex
cellular machinery of autophagy. The basal level of autophagy
occurs constantly in endothelial cells with the primary function
of clearance of misfolded proteins and dysfunctional organelles
that can be harmful to the cell (e.g., damaged mitochondria
producing excessive ROS). Moreover, autophagy is elicited by
different stimuli coming from both the intra- and intercellular
environments. These stimuli span from metabolic and redox
stressors, as in the case of nutritional starvation, to encompass
also dysregulation of ROS, hypoxia, DNA damage, and
mechanical shear stress. Under such circumstances, the role
of autophagy is generally cytoprotective through the activation
of pathways aimed to preserve the physiological balance. These
different functions cover a range from dynamic adjustment of
the bioenergetic and biosynthetic needs of endothelial cells
when metabolic stress, nutritional starvation, or angiogenesis
occur to playing a role in the production of eNOS and the
secretion of von Willebrand factor from Weibel−Palade bodies
in order to preserve the homeostasis balance.78−80 However,
dysregulated autophagy is also involved in ED.80 Even though
the mechanisms involved are not completely understood,
depending on the circumstances autophagy can switch from
cytoprotective function to those promoting endothelial
dysfunction. Given the importance of autophagy in ED, it is
worth remarking that even if different types of autophagy do
exist (chaperone-mediated, macro-, and microautophagy), they
are all related to lysosomes.81−83
Because there is no Raman marker for lysosomes, detection
of alterations at the lysosomal level in a label-free manner is
not possible. Recently, resonance Raman probes based on
BlackBerry Quencher 650 (BBQ-650) conjugated with N,N-
dimethylethylenediamine as a lysosome targeting moiety to
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visualize this cellular compartment were suggested. Application
of the 633 nm laser line with energy close to the absorption
maximum at 650 nm caused an increase in the intensity of the
bands.84 The same idea was applied to direct PDDA and 2-yne
to lysosomes (Figure 2C).55 Because of elevated lysosomal
accumulation of methylene blue, it was also suggested as a
promising lysosomal Raman reporter that can be imaged with
EPR-SRS tuned to the band at 1630 cm−1.56 The mechanism
underlying preferential lysosomal accumulation of probes is
protonation of the weak base used as the targeting group.84
Membrane-impermeable protonated amines are selectively
trapped in the lysosomes. As in the case of most of the
mitochondria-targeting moieties, excessive changes in the
lysosome environment and alkalization may alter their
functions in long-term tracing. Nevertheless, further optimiza-
tion of the structure−function relationship of reporters is
needed for such important organelles to be used more widely
for imaging.
4. DETECTION OF CELLULAR UPTAKE AND
ACCUMULATION OF SPECIFIC LABELED
MOLECULES
Undeniably, glucose is the major energy source for cells, and
alterations in glucose metabolism lead to diabetes.3 It is worthy
of note that increased cellular glucose uptake is used as
diagnostic indicator of tumor cells under PET or NMR
investigation. Thus, techniques allowing for cost-effective
imaging of the uptake and development of new effective
glucose-based probes or other probes to study the uptake of
other bioenergetic substrates are very attractive. SRS was used
to study the uptake of substituted D7-glucose based on the
distinct bands at 2060 and 2250 cm−1 and the analogue 3-O-
propargyl-D-glucose (3-OPG) at 2129 cm−1 using in vitro
models as well as ex vivo measurements of the brain (Figure
3A,B(a)).93 In order to minimize the possibility of band
overlap, 3-OPG was modified with 13C13C (denoted as 3-
OPG-13C3), which changed the characteristic band position to
2052 cm−1, and was simultaneously imaged in vitro.
Ratiometric images (C−D/13C13C) allowed comparison of
the efficiency of glucose incorporation into biomass in vitro and
classification of the anabolic activity of biomass synthesis in
descending order for normal prostate, kidney, cancer prostate,
and glioblastoma cell lines.86 Further studies showed that
lipids, nucleic acids, and proteins isolated from cells incubated
in D7-glucose contained deuterium in their structure,
suggesting de novo synthesis of D7-glucose. Then, multichannel
SRS imaging with a signal-unmixing method separated the
signals corresponding to the synthesis of lipids, proteins, and
glycogen de novo (denoted as CDL, CDP CDG, respectively).
The ratio of CDP to CDL indicated different glucose metabolic
activity in cardiac muscle, fat tissue, and liver of mice fed with
D7-glucose, which is consistent with their metabolic activity. A
similar approach applied to melanoma cell lines with varying
degrees of cellular differentiation revealed differences in
glycogen-accumulation phenotype and metabolic activity.94
Additionally, deuterated fat accumulation was observed in the
intestines of mice pup breast-fed by a mother drinking
deuterated water.95 Beside glucose SRS, peracetylated N-(4-
pentynoyl)mannosamine (Ac4ManNAl) glycan can be studied
with SRS.67
Figure 3. Compounds used to study intracellular transport tracking. (A) Chemical structures of D7-glucose, 3-OPG-13C3, BADY-anisomycin,
PhDY-anisomycin, and ponatinib. (B) SRS imaging of (a) PC-3 cells treated with D7-glucose for 48 h and then with 3-OPG-13C3 for 2 h, indicating
glucose incorporation (2133 cm−1, cyan hot), glucose uptake (2053 cm−1, red hot); (b) fixed SKBR3 cells treated with BADY-ANS (100 μM, 30
min); (c) PhDY-ANS (100 μM, 30 min); (d) KCL22 cells treated with ponatinib (5 μM, 1 h); (e) SK-BR-3 cells treated with neratinib (5 μM, 8
h); (f) SW480 cells treated with erlotinib (100 μM, 12 h). Images were acquired at 2940 cm−1 (CH3, proteins), 2219 cm
−1 (CC, PhDY-/BADY-
ANS), and 2221 cm−1 (CC, ponatinib). (C) Structures of the isotope-edited EPR-SRS probes 9CN-JCP (red), 9C15N-JCP (green), 913CN-JCP
(blue), and 913C15N-JCP (yellow) and SRS images of probes incubated with the A549 and H226 cell lines acquired at 2217 cm−1 (gGlu-9CN-JCP,
red), 2190 cm−1 (Leu 9C15N-JCP, green), 2166 cm−1 (EP-913CN-JCP, blue), and 2137 cm−1 (β-Gal-913C15N-JC, yellow). In panel (B), part (a) is
adapted with permission from ref 86. Copyright 2017 Royal Society of Chemistry. Parts (b) and (c) are from ref 87. CC BY 3.0. Part (d) is adapted
from ref 88. Copyright 2019 American Chemical Society. Part (e) is adapted from ref 90. CC BY-NC-ND 4.0. Part (f) is reproduced with
permission from ref 91. Copyright 2013 Royal Society of Chemistry. Panel (C) is adapted from ref 89. Copyright 2020 American Chemical Society.
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Accumulation of lipids in lipid droplets (LDs) and altered
composition and size of LDs have been recognized as
important pathophysiological elements of ED.18 The repertoire
of LDs identified in ED include LDs rich in highly unsaturated
lipids, which are assigned to inflammation, as well as LDs
featured by more saturated lipids linked to apoptosis, with
increased content of cholesterol and phospholipids.96 How-
ever, the mechanisms of their accumulation and the
mechanisms by which LDs contribute to ED are not clear.
Tracking of D-38 cholesterol metabolism was investigated by
using SRS, giving the advantage of high signal intensity over D-
7 cholesterol. D-38 cholesterol was shown to have no effect on
cellular processes and underlined the heterogeneity of
composition of neutral lipids between single LDs. Moreover,
it allowed for discrimination of the ratio of esterified to
nonesterified cholesterol. Accumulation of cholesterol in LDs
was recognized as a mechanism preventing toxicity and
overaccumulation of cholesterol in membranes, which affects
their stiffness.97 Another promising cholesterol-based SRS
probe, tagged with a phenyl diene, was shown to undergo
esterification and storage in LDs, proving that it mimics
cholesterol behavior in vitro and in vivo.98 Other factors
influencing changes in LD composition such as the presence of
deuterated and alkylated fatty acids were widely studied by
SRS, allowing the determination of fatty acid transport and a
description of their role in the cell.99−102 Lipidic structures,
including the ER and nuclear envelope, were visualized in
endothelial cells under inflammation with astaxanthin, a
carotenoid displaying resonantly enhanced bands at 1159
and 1523 cm−1 in spontaneous Raman spectroscopy using the
532 nm laser line.103 The phospholipid distribution, however,
was studied using either deuterated (D9)104 or alkyne-tagged
choline.66
The SRS technique was also reported to be promising to
establish transport, accumulation, and mechanism of action not
only of bioenergetic substrates and lipids but also small
biologically active molecules.87 Anisomicyn activates the
mitogen-activated protein kinase pathways JNK/SAPK1 and
p38/SAPK2, causing inhibition of protein synthesis. Their
modification with bis(aryl)butadiyne (BADY-ANS) or 5-
phenyl-2,4-pentadiyne (PhDY-ANS) were observed at 2219
cm−1, showing the cytoplasmatic distribution (Figure 3A,B-
A,B(b,c)). Additionally, the SRS signal is colocalized with the
ER-Tracker fluorescent dye distribution, indicating that the
labeled drugs might bind to ribosome subunits in a similar way
as anisomycin.87 Other promising anticancer-antimycin-type
depsipeptides labeled with PhDY were successfully imaged
with SRS. Structures containing a macrocyclic nine-membered
ring with an amide linkage to a 3-formamidosalicylate unit and
a PhDY label were detected at 10 μM concentration, while 50
μM PhDY induced absolute intracellular concentrations as
high as 1.74 mM. SRS imaging was in agreement with the ER-
Tracker fluorescent dye distribution. This colocalization agrees
with one of its known direct protein targets, Bcl2, an anti-
apoptotic protein localized primarily in the ER. Interestingly,
no significant colocalization with MitoTracker was observed,
despite the known antimycin activity in mitochondria, though
its strong correlation with lipids was presented.105 The authors
of this study highlighted that modification of drugs with a
Raman targeting group (here PhDY) and SRS imaging should
be considered as a relevant method of drug detection.
Interestingly, some drugs have functional groups allowing for
their direct detection in the silent region of the Raman
spectrum without the need to add a Raman reporter moiety.
This is the case with neratinib90 (Figure 3A,B(e)) and
erlotinib91 (Figure 3A,B(f)), which are tyrosine kinase
inhibitors (TKIs) that target epidermal growth factor receptor
(EGFR) and are both detected by spontaneous Raman
spectroscopy. SRS-based measurements of this type reduce
the time required for intracellular drug detection compared
with classical analytical methods (Figure 3A,B(d)). Further-
more, this approach could allow the drug intracellular
distribution to be studied. Comparison with the LysoTracker
and LysoSensor distribution confirmed the accumulation of
the TKI within acidic structures of the cell.88 Visualization of
drug accumulation can be performed using principally a
Figure 4. Structures of SRS ratiometric bis(aryl)butadiyne-based pH probes. Values of pKa(H) and the maximum and minimum band positions of
the alkyne (νmaxand νmin) and difference between these two values (Δνalkyne) are shown for each probe. Notes: aexperiments were carried out at a
compound concentration of 200 μM; bpKa(H) could not be determined. From ref 92. CC BY 3.0.
Journal of Medicinal Chemistry pubs.acs.org/jmc Perspective
https://doi.org/10.1021/acs.jmedchem.1c00051
J. Med. Chem. 2021, 64, 4396−4409
4404
fingerprint region of the spectrum collected from the
stimulated cell. SRS studies indicated an increased accumu-
lation of nilotinib and imatinib in lysosomes in contrast to
other kinase inhibitors (i.e., GNF2 and GNF5).106 In view of
the evidence for the endothelial toxicity of some TKIs and
many other anticancer agents,107,108 SRS-based studies on their
uptake and subcellular distribution in the endothelium might
perhaps offer a novel insight into their endothelial action and
be useful in studies aimed to develop endothelium-safe
chemotherapeutics.107
Other interesting applications of Raman probes have proved
to be useful to determine enzyme activity in vitro. Indeed,
enzyme activities in two human lung carcinoma models were
determined using Raman probes. Enzymatic substrates such as
γ-L-glutamyl(gGlu), L-leucyl (Leu), L-glutamyl-L-propyl (EP),
and β-D-galactosyl (β-Gal) conjugated with the isotopically
substituted nitrile group of the SRS-active scaffold 9CN-JCP
upon reaction with the appropriate enzymes exhibited sharp
Raman bands at 2217, 2190, 2166, and 2137 cm−1, respectively
(Figure 3C). With probes at concentrations of 10−20 μM, the
distribution and relative activity of four enzymes were imaged
simultaneously using SRS. Overall, the detected enzyme
activities were in agreement with their expression levels as
assessed by PCR.89
The application of Raman reporters also offers insight in
detecting and monitoring the pH in the cell milieu. Regulation
of intracellular and extracellular pH is essential for proper cell
proliferation, protein synthesis, and metabolism. Thanks to
their high Raman cross section, BADY-labeled compounds
were found to be useful in multiplex-type measurements. The
general idea of this approach is to combine a Raman reporting
group (here BADY) with a pH-responsive group. The change
in pH shifts the position of the band of the diyne group
assigned to a specific pH value. As a result, 13 compounds
were designed to cover the full pH range (Figure 4). The
authors described the quantification of the intramitochondrial
pH using the 13 compounds imaged inside human
adenocarcinoma cells (PC3) in the presence of nigericin, a
common fluorescence pH standard. Under these conditions,
the maximum and minimum values of the diyne group
wavenumber were determined to be 2221 and 2210 cm−1
when the pH was fixed at 5.5 and 7.5, respectively.
Furthermore, this compound was tested on cells treated with
the apoptosis-triggering drug etoposide. Cytosolic acidification
has been observed during apoptosis, and the new sensor
tracked the decrease in pH over time in response to etoposide
treatment.92
Recently in vitro and ex vivo SRS microscopy has been
receiving considerable attention as a new diagnostic tool.
Quantitative assessment of liver steatosis in nonalcoholic
steatohepatitis (NASH) was achieved with SRS imaging of
lipids, proteins, and DNA at 2850, 2930, and 2960 cm−1,
respectively. The results revealed that there was no significant
difference between the numbers of lipid droplets in the control
samples and the pathologically altered samples, while the
average size of lipid droplets in the tissue was a discriminating
factor. Importantly, hematoxylin and eosin or ORO staining
failed to detect microvesicular steatosis that can be a hallmark
of early-stage disease.109 Additionally, brain tumor detection
was possible in fresh biopsy samples,110,111 opening the
prospect for application of SRS as an intraoperative diagnostic
tool.112 The potential of SRS over routine histological staining,
such as analysis of fresh samples, short time of image
acquisition, and comparable results for different tissue
types,113 leads to the conclusion that this technique would
be a promising tool in a clinically relevant setting of
intraoperative diagnosis.
5. SUMMARY AND DISCUSSION
Over the past decade, Raman imaging has proven to be useful
for detecting biochemical changes in ED in various models of
cardiovascular diseases ex vivo, in vivo, as well as in endothelial
cell models in vitro mimicking endothelial pathology. However,
it has been challenging to study the primary cellular processes
occurring in specific endothelial organelles using this
technique. Furthermore, ED is related to changes occurring
in the mitochondria, nucleus, endoplasmic reticulum, and
lysosomes, hence, better understanding of their relative
contributions to ED is needed. The nucleus or mitochondria
can be imaged via Raman microscopy because of the
characteristic signals from DNA and cytochrome c, respec-
tively, but they are not always so specifically related to these
organelles. Nonetheless, there is no Raman marker for small
organelles (e.g., lysosomes). Interestingly, there have been a
vast number of studies focused on the development of Raman
reporters designed to enhance the performance of Raman
imaging with a special focus on SRS-based approaches that
could be specifically designed to study a given organelle
associated with the development of ED. Each reporter
possesses in its structure the “targeting moiety” or “sensing
group” that is responsible for directing it into a certain
organelle along with the molecular reporting group that is
characterized by a unique, well-separated Raman signal. The
actual subcellular localization of designed Raman reporters is
frequently estimated in reference to fluorescence microscopy.
Thus, the application of Raman reporters seems to be a
promising approach in achieving better sensitivity of Raman
imaging (both spontaneous and stimulated) and offering an
attractive possibility to identify and image biochemical
alterations at the subcellular level in a given organelle.
Although there are a few candidates for Raman reporters
targeting the nucleus or mitochondria, the propositions of
Raman reporters for ER are rather scarce. Still, the specificity
of Raman reporters to given organelles represents their
limitation as well as their ability to alter the organelles’
function. For example, MitoBADY designed to target
mitochondria may accumulate in, e.g., lipids, while positively
charged mitochondrial probes can alter the mitochondrial
membrane potential.
An important asset of Raman-based studies, in particular
SRS, described in this review, is the ability of this methodology
to visualize the uptake and intracellular distribution of labeled
glucose, cholesterol, and other bioenergetic substrates or drugs.
Chemical modification of such molecules with deuterium
labeling or coupling with Raman reporting moiety opens new
avenue in labeled Raman microscopy studies in biomedicine.
In summary, in this review we aimed to provide evidence
that Raman reporters can be used not only to target the
subcellular structures or follow the fate of labeled molecules
but also to monitor particular subcellular processes, which
could substantially expand our understanding of the bio-
chemical alteration of ED at the subcellular level. The
development and optimization of Raman probes specifically
designed to visualize alterations in biochemical content on the
subcellular level will surely bring important novel opportu-
nities. Since SRS in combination with the use of Raman
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reporters has not yet been used to study ED, that approach can
be considered as an exciting new experimental method for in-
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